Harnessing proteases for T regulatory cell immunotherapy
Open Access
- 1 June 2020
- journal article
- review article
- Published by Wiley in European Journal of Immunology
- Vol. 50 (6), 770-778
- https://doi.org/10.1002/eji.201948270
Abstract
The immune system is tightly regulated by a subset of T cells defined as regulatory T cells (Tregs). Tregs maintain immune homeostasis by restraining unwarranted immune cell activation and effector function. Here, we discuss an important but underappreciated role of proteases in controlling Treg function. Proteases regulate a number of vital processes that determine T cell immune responses and some of them such as furin, ADAM (through regulating LAG receptor), MALT, and asparaginyl endopeptidase are implicated in Treg immunobiology. Targeted protease inhibition, using either small molecule inhibitors or gene deficient mice has demonstrated their specificity in modulating Treg function in experimental murine models. These data further highlight the ability of proteases to specifically regulate Tregs but no other T effector lineages. Taken together, it is apparent that incorporating proteases as targets within Treg cell engineering protocols may enable generation of robust Treg cellular therapeutics. These engineered Tregs may possess enhanced regulatory function along with resistance to lineage deviation in inflammatory disease such as colitis and graft versus host disease. Within this review, we summarize research on the role of proteases in regulating Treg function and discuss the translational potential of harnessing Treg function by targeting protease driven regulatory pathways.Keywords
Funding Information
- Academy of Medical Sciences (SBF003\1129)
- Newcastle University (LF‐AW_EMEA‐19‐400028)
- Cancer Research UK (C71069/A29822)
This publication has 83 references indexed in Scilit:
- Regulatory T cells: recommendations to simplify the nomenclatureNature Immunology, 2013
- Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4 + T CellsScience, 2010
- The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammationNature Immunology, 2009
- The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper CellsCell, 2006
- Scurfin (FoxP3) Controls T-Dependent Immune Responses In Vivo Through Regulation of CD4+ T Cell Effector FunctionThe Journal of Immunology, 2003
- Foxp3 programs the development and function of CD4+CD25+ regulatory T cellsNature Immunology, 2003
- Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX)Journal of Medical Genetics, 2001
- The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3Nature Genetics, 2001
- A Novel Transcription Factor, T-bet, Directs Th1 Lineage CommitmentCell, 2000
- The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T CellsCell, 1997